Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A22496 | 24517227 | Endocrinology | Nicotine improves obesity and hepatic steatosis and ER stress in diet-induced obese male rats. | 2014 | Details |
| A22501 | 24516489 | J Res Med Sci | The effect of magnesium supplementation and weight loss on liver enzymes in patients with nonalcoholic fatty liver disease. | 2013 | Details |
| A22504 | 24512497 | J Clin Endocrinol Metab | Nonalcoholic Fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance. | 2014 | Details |
| A22512 | 24500395 | Eur J Pediatr | Serum hepcidin levels and iron metabolism in obese children with and without fatty liver: case-control study. | 2014 | Details |
| A22519 | 24495527 | Proc Nutr Soc | 'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk. | 2014 | Details |
| A22522 | 24492753 | Am J Gastroenterol | Fatty pancreas, insulin resistance, and β-cell function: a population study using fat-water magnetic resonance imaging. | 2014 | Details |
| A22525 | 24491369 | Semin Pediatr Surg | Nonalcoholic fatty liver disease and bariatric surgery in adolescents. | 2013 | Details |
| A22528 | 24489924 | PLoS One | Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A22529 | 24489777 | PLoS One | Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats. | 2014 | Details |
| A22532 | 24488901 | Eur Rev Med Pharmacol Sci | Non-alcoholic fatty liver disease (NAFLD) and MTHFR 1298A > C gene polymorphism. | 2014 | Details |
| A22534 | 24486145 | Diabetes Metab | Adiponectin: A multitasking player in the field of liver diseases. | 2014 | Details |
| A22541 | 24477042 | Am J Clin Nutr | Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals. | 2014 | Details |
| A22550 | 24471572 | J Clin Endocrinol Metab | Nonalcoholic fatty liver disease, liver fibrosis, and cardiometabolic risk factors in adolescence: a cross-sectional study of 1874 general population adolescents. | 2014 | Details |
| A22552 | 24468600 | J Pediatr Endocrinol Metab | Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease. | 2014 | Details |
| A22558 | 24463897 | Arq Bras Cir Dig | Nonalcoholic steatohepatitis on preoperative period of gastric bypass: lack of correlation with degree of obesity. | 2013 | Details |
| A22563 | 24461315 | Nutr Res | Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients. | 2013 | Details |
| A22565 | 24460502 | Gynecol Endocrinol | Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women. | 2014 | Details |
| A22567 | 24458218 | J Pediatr Gastroenterol Nutr | Association of INSIG2 rs9308762 with ALT level independent of BMI. | 2014 | Details |
| A22579 | 24445237 | Biol Chem | Citrate--new functions for an old metabolite. | 2014 | Details |
| A22580 | 24445219 | J Hepatol | Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension. | 2014 | Details |
| A22581 | 24445216 | J Hepatol | Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice. | 2014 | Details |
| A22584 | 24445047 | J Nutr Biochem | Role of immunodeficient animal models in the development of fructose induced NAFLD. | 2013 | Details |
| A22588 | 24440943 | J Clin Gastroenterol | Low awareness of nonalcoholic fatty liver disease among patients at high metabolic risk. | 2015 | Details |
| A22589 | 24440936 | J Clin Gastroenterol | Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology. | 2015 | Details |
| A22593 | 24436353 | Am J Physiol Gastrointest Liver Physiol | Dissociation of hepatic insulin resistance from susceptibility of nonalcoholic fatty liver disease induced by a high-fat and high-carbohydrate diet in mice. | 2014 | Details |
| A22596 | 24428929 | BMC Genomics | Alterations in hepatic miRNA expression during negative energy balance in postpartum dairy cattle. | 2014 | Details |
| A22598 | 24428677 | Expert Opin Pharmacother | New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease. | 2014 | Details |
| A22604 | 24418870 | J Nutr Sci Vitaminol (Tokyo) | Transgenerational effects on the liver and pancreas resulting from maternal vitamin D restriction in mice. | 2013 | Details |
| A22605 | 24418844 | Int J Obes (Lond) | Reduced hepatic aquaporin-9 and glycerol permeability are related to insulin resistance in non-alcoholic fatty liver disease. | 2013 | Details |
| A22607 | 24417951 | Best Pract Res Clin Endocrinol Metab | Adiponectin as a routine clinical biomarker. | 2013 | Details |
| A22610 | 24417071 | Klin Med (Mosk) | [Obesity and diseases of digestive organs]. | 2013 | Details |
| A22616 | 24409043 | World J Gastroenterol | Non-alcoholic fatty liver disease and liver transplantation: outcomes and advances. | 2013 | Details |
| A22617 | 24407920 | Diabetologia | The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial. | 2014 | Details |
| A22618 | 24404139 | PLoS One | Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression. | 2014 | Details |
| A22626 | 24401223 | Atherosclerosis | Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. | 2013 | Details |
| A22628 | 24397589 | Lipids Health Dis | Differential patterns of insulin secretion and sensitivity in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease versus patients with type 2 diabetes mellitus alone. | 2014 | Details |
| A22630 | 24396693 | Endocrinol Metab (Seoul) | Association of serum adipocyte-specific Fatty Acid binding protein with Fatty liver index as a predictive indicator of nonalcoholic Fatty liver disease. | 2013 | Details |
| A22631 | 24396649 | Endocrinol Metab (Seoul) | Tumor Necrosis Factor-α as a Predictor for the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Follow-Up Study. | 2013 | Details |
| A22634 | 24393106 | Antioxid Redox Signal | Mitochondrial dysfunction in obesity-associated nonalcoholic fatty liver disease: the protective effects of pomegranate with its active component punicalagin. | 2014 | Details |
| A22640 | 24390241 | Mol Biol Rep | Serum lipocalin-2, cathepsin S and chemerin levels and nonalcoholic fatty liver disease. | 2014 | Details |
| A22645 | 24385405 | Adv Ther | Effect of metformin on ballooning degeneration in nonalcoholic steatohepatitis (NASH): when to use metformin in nonalcoholic fatty liver disease (NAFLD). | 2014 | Details |
| A22647 | 24384368 | Semin Cell Dev Biol | Nuclear envelope-related lipodystrophies. | 2013 | Details |
| A22651 | 24381750 | J Nutr Metab | Cut-Off Values of Visceral Adiposity to Predict NAFLD in Brazilian Obese Adolescents. | 2013 | Details |
| A22652 | 24381427 | Indian J Clin Biochem | A Study of Carotid Atherosclerosis in Patients with Non-alcoholic Fatty Liver Disease. | 2012 | Details |
| A22653 | 24380887 | Biochem Pharmacol | Brain metabolic dysfunction at the core of Alzheimer's disease. | 2013 | Details |
| A22654 | 24379092 | Orv Hetil | [The role of fetuin-A in cardiovascular diseases]. | 2014 | Details |
| A22658 | 24378273 | Ann Hepatol | Effects of bile acid sequestration on hepatic steatosis in obese mice. | 2014 | Details |
| A22659 | 24378270 | Ann Hepatol | Statin use is not associated with liver related mortality. | 2014 | Details |
| A22661 | 24377455 | Nutrition | Effects of bayberry juice on inflammatory and apoptotic markers in young adults with features of non-alcoholic fatty liver disease. | 2014 | Details |
| A22662 | 24377452 | Nutrition | Central obesity and altered peripheral adipose tissue gene expression characterize the NAFLD patient with insulin resistance: Role of nutrition and insulin challenge. | 2014 | Details |
| A22671 | 24373555 | Nutr J | Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial. | 2013 | Details |
| A22672 | 24373179 | Diabetes Obes Metab | APOE*3Leiden.CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome. | 2014 | Details |
| A22678 | 26528002 | Clujul Med | From NAFLD to Cardiovascular Disease. Is it (Still) the Metabolic Syndrome? | 2014 | Details |
| A22679 | 26417275 | EXCLI J | Non-alcoholic fatty liver disease, diet and gut microbiota. | 2014 | Details |
| A22683 | 26058106 | Eksp Klin Gastroenterol | [New metabolic index in the diagnosis of insulin resistance in patients with nonalcoholic fatty liver disease]. | 2014 | Details |
| A22684 | 26015978 | Mol Ther Methods Clin Dev | AAV8-mediated Sirt1 gene transfer to the liver prevents high carbohydrate diet-induced nonalcoholic fatty liver disease. | 2014 | Details |
| A22687 | 25937854 | EPMA J | 4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics. | 2014 | Details |
| A22692 | 25859286 | Clin Epigenetics | Leucine alters hepatic glucose/lipid homeostasis via the myostatin-AMP-activated protein kinase pathway - potential implications for nonalcoholic fatty liver disease. | 2014 | Details |
| A22694 | 25816629 | Vopr Pitan | [An analysis of the efficacy of low-calorie and isocaloric diets in obese patients with nonalcoholic steatohepatitis]. | 2014 | Details |
| A22707 | 24366230 | Curr Opin Lipidol | Nutrition, nonalcoholic fatty liver disease and the microbiome: recent progress in the field. | 2014 | Details |
| A22710 | 24365277 | Med Hypotheses | Nonalcoholic fatty liver disease (NAFLD): a new risk factor for adverse cardiovascular events in dialysis patients. | 2013 | Details |
| A22711 | 24364104 | Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi | [Changes of serum aminotransferase in children with obstructive sleep apnea hypopnea syndrome]. | 2013 | Details |
| A22713 | 24363514 | World J Gastroenterol | Cross-talk between the thyroid and liver: a new target for nonalcoholic fatty liver disease treatment. | 2013 | Details |
| A22714 | 24362075 | J Hepatol | Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation. | 2013 | Details |
| A22715 | 24361606 | Biochim Biophys Acta | Lipoic acid prevents fructose-induced changes in liver carbohydrate metabolism: role of oxidative stress. | 2013 | Details |
| A22718 | 24360972 | J Diabetes Complications | Serum ferritin is associated with non-alcoholic fatty liver disease and decreased Β-cell function in non-diabetic men and women. | 2013 | Details |
| A22721 | 24358044 | Hepat Mon | The effect of helicobacter pylori eradication on liver fat content in subjects with non-alcoholic Fatty liver disease: a randomized open-label clinical trial. | 2013 | Details |
| A22731 | 24351080 | Liver Int | Expression of toll-like receptors 1-5 but not TLR 6-10 is elevated in livers of patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A22736 | 24348536 | Gastroenterol Res Pract | Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls. | 2013 | Details |
| A22741 | 24342243 | Food Chem Toxicol | The ethanol extract of Zingiber zerumbet Smith attenuates non-alcoholic fatty liver disease in hamsters fed on high-fat diet. | 2013 | Details |
| A22746 | 24335764 | Int J Obes (Lond) | Kefir improves fatty liver syndrome by inhibiting the lipogenesis pathway in leptin-deficient ob/ob knockout mice. | 2013 | Details |
| A22747 | 24333862 | J Hepatol | A population-based study on the prevalence of NASH using scores validated against liver histology. | 2013 | Details |
| A22748 | 24333444 | Biochem Biophys Res Commun | Mechanisms underlying hypertriglyceridemia in rats with monosodium L-glutamate-induced obesity: evidence of XBP-1/PDI/MTP axis activation. | 2013 | Details |
| A22755 | 24327959 | Mol Metab | Phenotypic comparison of common mouse strains developing high-fat diet-induced hepatosteatosis. | 2013 | Details |
| A22757 | 24327268 | Hepatology | Hepatocyte-specific Ptpn6 deletion promotes hepatic lipid accretion, but reduces NAFLD in diet-induced obesity: potential role of PPARγ. | 2014 | Details |
| A22759 | 24326426 | Am J Physiol Endocrinol Metab | Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats. | 2013 | Details |
| A22762 | 24324835 | PLoS One | Nutrigenomics of high fat diet induced obesity in mice suggests relationships between susceptibility to fatty liver disease and the proteasome. | 2013 | Details |
| A22765 | 24322742 | Hepatobiliary Pancreat Dis Int | Novel anti-diabetic agents in non-alcoholic fatty liver disease: a mini-review. | 2013 | Details |
| A22766 | 24322188 | Arq Gastroenterol | Nonalcoholic fatty liver disease in menopausal women. | 2014 | Details |
| A22767 | 24321741 | Eur J Med Res | Dietary fructose enhances the incidence of precancerous hepatocytes induced by administration of diethylnitrosamine in rat. | 2013 | Details |
| A22768 | 24321532 | J Pediatr | Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease. | 2013 | Details |
| A22771 | 24320032 | Curr Pharm Des | The metabolic syndrome and chronic liver disease. | 2014 | Details |
| A22775 | 24316518 | J Hepatol | Dietary glycotoxins exacerbate progression of experimental fatty liver disease. | 2013 | Details |
| A22776 | 24316260 | Gastroenterology | Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. | 2013 | Details |
| A22778 | 24314869 | J Nutr Biochem | Effects of a Lactobacillus paracasei B21060 based synbiotic on steatosis, insulin signaling and toll-like receptor expression in rats fed a high-fat diet. | 2013 | Details |
| A22780 | 24313052 | Rev Med Suisse | [Dysmetabolic hyperferritinemia: a new target for treatment?]. | 2013 | Details |
| A22783 | 24307947 | J Lipids | Grape seed proanthocyanidin rescues rats from steatosis: a comparative and combination study with metformin. | 2013 | Details |
| A22784 | 24306155 | Obes Res Clin Pract | Low 25-hydroxyvitamin D level is associated with insulin sensitivity in obese adolescents with non-alcoholic fatty liver disease. | 2014 | Details |
| A22785 | 24304731 | Rev Invest Clin | [Decrease of liver fat content by aerobic exercise or metformin therapy in overweight or obese women]. | 2014 | Details |
| A22786 | 24303796 | Clin Endocrinol (Oxf) | Low serum sex hormone-binding globulin is associated with nonalcoholic fatty liver disease in type 2 diabetic patients. | 2013 | Details |
| A22792 | 24302567 | Mol Nutr Food Res | Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds. | 2013 | Details |
| A22797 | 24298105 | Clin Med (Lond) | Low vitamin D levels are associated with increased risk for fatty liver disease among non-obese adults. | 2013 | Details |
| A22798 | 24297186 | Rev Endocr Metab Disord | Adiponectin signaling in the liver. | 2014 | Details |
| A22799 | 24295779 | Biochim Biophys Acta | Omega-3 phospholipids from fish suppress hepatic steatosis by integrated inhibition of biosynthetic pathways in dietary obese mice. | 2014 | Details |
| A22808 | 26355775 | J Clin Transl Hepatol | Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention. | 2013 | Details |
| A22810 | 26202295 | Hepatol Int | Lean NASH: distinctiveness and clinical implication. | 2013 | Details |
| A22811 | 26202294 | Hepatol Int | An integrated view of liver injury and disease progression in nonalcoholic steatohepatitis. | 2013 | Details |
| A22815 | 26182139 | Clin J Gastroenterol | A rapidly progressive and fatal case of nonalcoholic steatohepatitis following pancreaticoduodenectomy. | 2013 | Details |
| A22819 | 24287794 | Endocrine | Non-alcoholic fatty liver disease: a diabetologist's perspective. | 2013 | Details |
| A22823 | 24284392 | Int J Mol Sci | Lessons from mouse models of high-fat diet-induced NAFLD. | 2013 | Details |